Arecor Therapeutics Management
Management criteria checks 3/4
Arecor Therapeutics' CEO is Sarah Howell, appointed in Jun 2015, has a tenure of 9.42 years. total yearly compensation is £439.00K, comprised of 59.2% salary and 40.8% bonuses, including company stock and options. directly owns 2.3% of the company’s shares, worth €794.93K. The average tenure of the management team and the board of directors is 5.5 years and 7.2 years respectively.
Key information
Sarah Howell
Chief executive officer
UK£439.0k
Total compensation
| CEO salary percentage | 59.2% |
| CEO tenure | 9.4yrs |
| CEO ownership | 2.3% |
| Management average tenure | 5.5yrs |
| Board average tenure | 7.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -UK£9m |
| Mar 31 2024 | n/a | n/a | -UK£9m |
| Dec 31 2023 | UK£439k | UK£260k | -UK£9m |
| Sep 30 2023 | n/a | n/a | -UK£9m |
| Jun 30 2023 | n/a | n/a | -UK£9m |
| Mar 31 2023 | n/a | n/a | -UK£9m |
| Dec 31 2022 | UK£421k | UK£250k | -UK£9m |
| Sep 30 2022 | n/a | n/a | -UK£8m |
| Jun 30 2022 | n/a | n/a | -UK£7m |
| Mar 31 2022 | n/a | n/a | -UK£7m |
| Dec 31 2021 | UK£343k | UK£218k | -UK£6m |
Compensation vs Market: Sarah's total compensation ($USD553.43K) is about average for companies of similar size in the German market ($USD474.43K).
Compensation vs Earnings: Sarah's compensation has increased whilst the company is unprofitable.
CEO
Sarah Howell (49 yo)
9.4yrs
Tenure
UK£439,000
Compensation
Dr. Sarah Jennifer Howell, Ph.D. has been the Chief Executive Officer of Arecor Therapeutics PLC since June 2015. Having joined in 2011 as Chief Operating Officer and Executive Director. During her time at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 9.4yrs | UK£439.00k | 2.3% € 794.9k | |
| Chief Scientific Officer | 17.8yrs | no data | no data | |
| Senior Vice President of Development | 1.3yrs | no data | no data | |
| Chief Business Officer | 1.6yrs | no data | no data |
5.5yrs
Average Tenure
Experienced Management: 6UI's management team is seasoned and experienced (5.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.6yrs | UK£439.00k | 2.3% € 794.9k | |
| Independent Non-Executive Director | 3.5yrs | UK£40.00k | 0.051% € 17.6k | |
| Non-Executive Director | no data | UK£35.00k | 0.48% € 166.5k | |
| Non-Executive Chairman | 8.2yrs | UK£80.00k | 0.59% € 205.1k | |
| Independent Non-Executive Director | 7.2yrs | UK£35.00k | 0.31% € 106.0k | |
| Member of Global Diabetes Scientific Advisory Board | 7.2yrs | no data | no data | |
| Member of Global Diabetes Scientific Advisory Board | 7.2yrs | no data | no data | |
| Member of Global Diabetes Scientific Advisory Board | 7.2yrs | no data | no data | |
| Independent Non-Executive Director | 3.5yrs | UK£40.00k | 0.072% € 24.9k |
7.2yrs
Average Tenure
62.5yo
Average Age
Experienced Board: 6UI's board of directors are considered experienced (7.2 years average tenure).